Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 7, 2007, Pages 485-490

  Riedel, S ^a   Beekmann, S E ^a   Heilmann, K P ^a   Richter, S S ^a   Garcia De Lomas, J ^b   Ferech, M ^c   Goosens, H ^c   Doern, G V ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 34347400170     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0321-5     Document Type: Article

References (15)

1. Felmingham D, Grüneberg RN, the Alexander Project Group (2000) The Alexander project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. JAC 45:191-203
2. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN et al (2003) The Alexander project 1998-2002: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. JAC 52:229-246
3. Klugman KP (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3:171-196
4. Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Doern GV (2005) Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A β-hemolytic streptococci in 2002-2003: results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 25:148-156
5. Jones ME, Blosser-Middleton RS, Critchley IA, Karlowsky JA, Thornsberry C, Sahm DF (2003) In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001. CMI 9:590-599
6. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB (2001) Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 45:1721-1729
7. Goossens H, Ferech M, Vander Stichele R, Elseviers M (2005) Outpatient antibiotic use in Europe and association with resistance: a cross national database study. Lancet 365:579-587
8. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R (2002) Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. JCM 40:159-164
9. Bronzwaer SL, Cars O, Bücholz U (2002) European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278-282
10. Melander E, Ekdahl K, Jönsson G, Mölstad S (2000) Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 19:1172-1177
11. Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing: approved standard and informational supplement M100-S16. CLSI, Wayne, PA
12. Chen DK, McGeer A, de Azavedo JC, Low DE (1999) Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada, Canadian Bacterial Surveillance Network. N Engl J Med 341:233-239
13. World Health Organization (2004) Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. WHO, Oslo, Norway
14. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 58:401-407
15. Vander Stichele R, Elseviers M, Ferech M et al (2004) European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol 58:419-428